Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
FlowView Diagnostics logo — AI-powered intelligent decision support for precise and auto...

FlowView Diagnostics

AI-powered intelligent decision support for precise and automated flow cytometry data analysis.

Founded 2020 The Netherlands The Netherlands 3 employees Series A Total: $1.05M Health Care, Information Technology

General Information

Company Name FlowView Diagnostics
Founded Year 2020
Location The Netherlands The Netherlands
Employees 3
Industries Health Care, Information Technology
Funding Stage Series A
Business Model SaaS, B2B, B2B2C
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with FlowView Diagnostics. To contact FlowView Diagnostics, visit flowview.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FlowView Diagnostics compare?

A PDF of FlowView Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FlowView Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FlowView Diagnostics

FlowView Diagnostics is an innovative player in the intersection of Health Care and Information Technology, established in 2020 and headquartered in The Netherlands. The company specializes in AI-powered flow cytometry solutions, offering the Asudes platform, which utilizes the patented Eclipse algorithm to automate complex data analysis in healthcare.

As a pioneering entity, FlowView Diagnostics aims to make flow cytometry analysis both accessible and actionable for its target users, including healthcare professionals and Clinical Research Organizations (CROs). Through automation, the company enhances data consistency and visualization, providing assurance and efficiency in complex medical assessments.

The company secured a €2.70M Seed Round investment on 24 June 2022, backed by investor Amatis. This infusion of capital underscores the confidence in FlowView Diagnostics as a forward-thinking enterprise capable of advancing AI applications in medical data analysis.

Business keywords: AI-driven Solutions, Flow Cytometry, Intelligent Decision Support, Healthcare Analytics, Clinical Research Organizations, Automated Data Analysis, Disease-specific Cell Identification, Biomedical Innovation, Eclipse Algorithm, Cloud-based Software, Data Visualization, Standardized Protocols, Medical Parameters Analysis, Research Collaboration

Services & Products

Automated flow cytometry data analysis
AI algorithm for cell detection
Deterministic output for consistent results
Advanced data visualization

Target Customers

Laboratories Hospitals Research teams Clinical Research Organizations (CROs) Healthcare professionals

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €310.00K 1
Health Venture
Health Venture
01 Jun 2024
Seed $390.00K 1
Health Venture
Health Venture
01 Jul 2023
Seed $250.00K 1
Health Venture
Health Venture
01 Jul 2022
Seed €100.00K 1
Health Venture
Health Venture
01 Feb 2021
Seed Undisclosed 1
Health Venture
Health Venture
01 Apr 2020

FlowView Diagnostics Alternatives & Competitors

View All Alternatives
FlowView Diagnostics vs
ProtoLytic, LLC
ProtoLytic, LLC United States

ProtoLytic has automated the evidence-based decision support system, to reduce time to quality care.

Venture round
10 employees
Biotechnology, Health Care
FlowView Diagnostics vs
Atropos Health
Atropos Health United States

The future of evidence-based medicine.

Series B
59 employees
Health Care, Information Technology
FlowView Diagnostics vs
Medical Informatics Corp.
Medical Informatics Corp. United States

Savings Lives Bit By Bit.

Series B
88 employees
Health Care, Information Technology
View all alternatives

FAQ About FlowView Diagnostics

AI-powered intelligent decision support for precise and automated flow cytometry data analysis.
FlowView Diagnostics was founded in 2020.
FlowView Diagnostics is headquartered in The Netherlands.
FlowView Diagnostics operates in Health Care and Information Technology. Its work centres on AI-driven Solutions, Flow Cytometry, Intelligent Decision Support and Healthcare Analytics. Its customers include Laboratories, Hospitals and Research teams.
FlowView Diagnostics has a SaaS, B2B and B2B2C business model. Its revenue comes from Subscription, Usage Based and Service Fee.
FlowView Diagnostics has approximately 3 employees.
FlowView Diagnostics has completed 5 funding rounds, raising a total of $1.05M. The latest funding stage is Series A.
FlowView Diagnostics offers: Automated flow cytometry data analysis, AI algorithm for cell detection, Deterministic output for consistent results, Advanced data visualization.
Top alternatives and competitors to FlowView Diagnostics include ProtoLytic, LLC, Atropos Health, Medical Informatics Corp., Molecular Health, IgniteData. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FlowView Diagnostics and ProtoLytic, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FlowView Diagnostics, https://bouncewatch.com/company/flowview-diagnostics, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes